Market Research Report
NORTH AMERICA ANTIFUNGAL AGENTS MARKET 2018-2026
|Published by||Inkwood Research||Product code||492773|
|Published||Content info||78 Pages
Delivery time: 2-3 business days
|NORTH AMERICA ANTIFUNGAL AGENTS MARKET 2018-2026|
|Published: August 6, 2018||Content info: 78 Pages||
Huge investments made for drug productions, along with the government initiatives related to fungal infections and their treatment are driving growth in the North America antifungal agents market. Over the forecast years of 2018-2026, the market is likely to showcase a CAGR of 2.80%.
Canada and the United States are the major markets analyzed in this report. The US antifungal agents market captured a dominant market share in the year 2017. The country is blessed with the presence of a number of global pharmaceutical giants that are continuously engaged in the development of new and innovative antifungal drugs. Canada too is witnessing a surge in fungal infections and is expected to show a healthy demand for the antifungal agents market.
Companies like Merck Co, Kramer Laboratories, Novartis, Abbott Laboratories, Johnson & Johnson, GlaxoSmithKline, Astellas Pharma Inc., Baxter, Arbor Pharmaceuticals Inc., Vertex Pharmaceuticals, Sanofi- Aventis, Teva Pharmaceuticals, and Pfizer are competing in this market.